# Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer

> **NCT07675421** · NA · RECRUITING · sponsor: **Federal University of Minas Gerais** · enrollment: 66 (estimated)

## Conditions studied

- Head and Neck Cancers

## Interventions

- **DIETARY_SUPPLEMENT:** HMB, hydroxymethylbutyrate
- **DIETARY_SUPPLEMENT:** Maltodextrin (Placebo)

## Key facts

- **NCT ID:** NCT07675421
- **Lead sponsor:** Federal University of Minas Gerais
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-01
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-11-30
- **Target enrollment:** 66 (ESTIMATED)
- **Last updated:** 2026-06-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07675421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07675421, "Impact of HMB Supplementation on Inflammation and Outcomes in Head and Neck Cancer". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07675421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*